Canada
· Delayed Price · Currency is CAD Blueberries Medical Statistics
Total Valuation
Blueberries Medical has a market cap or net worth of CAD 7.98 million. The enterprise value is 7.54 million.
| Market Cap | 7.98M |
| Enterprise Value | 7.54M |
Important Dates
The next estimated earnings date is Wednesday, November 27, 2024.
| Earnings Date | Nov 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Blueberries Medical has 399.03 million shares outstanding. The number of shares has increased by 57.88% in one year.
| Shares Outstanding | 399.03M |
| Shares Change (YoY) | +57.88% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.66% |
| Owned by Institutions (%) | n/a |
| Float | 152.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 21.51 |
| PB Ratio | 5.58 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.85 |
| EV / Sales | 26.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -10.13 |
Financial Position
The company has a current ratio of 3.35, with a Debt / Equity ratio of 0.83.
| Current Ratio | 3.35 |
| Quick Ratio | 1.54 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -66.46 |
Financial Efficiency
Return on equity (ROE) is -119.10% and return on invested capital (ROIC) is -41.59%.
| Return on Equity (ROE) | -119.10% |
| Return on Assets (ROA) | -32.54% |
| Return on Capital (ROIC) | -41.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.12 |
| Inventory Turnover | 0.94 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 2.01 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 57.68 |
| Average Volume (20 Days) | 19,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Blueberries Medical had revenue of CAD 288,289 and -1.29 million in losses. Loss per share was -0.00.
| Revenue | 288,289 |
| Gross Profit | 101,923 |
| Operating Income | -1.25M |
| Pretax Income | -1.29M |
| Net Income | -1.29M |
| EBITDA | -1.06M |
| EBIT | -1.25M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 452,462 in cash and 11,914 in debt, giving a net cash position of 440,548 or 0.00 per share.
| Cash & Cash Equivalents | 452,462 |
| Total Debt | 11,914 |
| Net Cash | 440,548 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 1.43M |
| Book Value Per Share | 0.00 |
| Working Capital | 1.01M |
Cash Flow
In the last 12 months, operating cash flow was -742,846 and capital expenditures -1,332, giving a free cash flow of -744,178.
| Operating Cash Flow | -742,846 |
| Capital Expenditures | -1,332 |
| Free Cash Flow | -744,178 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 35.35% |
| Operating Margin | -432.61% |
| Pretax Margin | -446.76% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -258.14% |
Dividends & Yields
Blueberries Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -57.88% |
| Shareholder Yield | -57.88% |
| Earnings Yield | -20.80% |
| FCF Yield | -9.32% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Blueberries Medical has an Altman Z-Score of -12.38. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.38 |
| Piotroski F-Score | n/a |